Literature DB >> 32947045

Advances in the preparation and synthesis of heparin and related products.

Sultan N Baytas1, Robert J Linhardt2.   

Abstract

Heparin is a naturally occurring glycosaminoglycan from livestock, principally porcine intestine, and is clinically used as an anticoagulant drug. A limitation to heparin production is that it depends on a single animal species and potential problems have been associated with animal-derived heparin. The contamination crisis in 2008 led to a search for new animal sources and the investigation of non-animal sources of heparin. Over the past 5 years, new animal sources, chemical, and chemoenzymatic methods have been introduced to prepare heparin-based drugs. In this review, we describe advances in the preparation and synthesis of heparin and related products.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bioengineered heparin.; Chemoenzymatic synthesis; Heparin; LMWH; Synthetic heparin

Year:  2020        PMID: 32947045      PMCID: PMC7718634          DOI: 10.1016/j.drudis.2020.09.011

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  111 in total

1.  Chemoenzymatic design of heparan sulfate oligosaccharides.

Authors:  Renpeng Liu; Yongmei Xu; Miao Chen; Michel Weïwer; Xianxuan Zhou; Arlene S Bridges; Paul L DeAngelis; Qisheng Zhang; Robert J Linhardt; Jian Liu
Journal:  J Biol Chem       Date:  2010-08-21       Impact factor: 5.157

2.  Functional and structural characterization of a heparanase.

Authors:  Lisa Bohlmann; Gregory D Tredwell; Xing Yu; Chih-Wei Chang; Thomas Haselhorst; Moritz Winger; Jeffrey C Dyason; Robin J Thomson; Joe Tiralongo; Ifor R Beacham; Helen Blanchard; Mark von Itzstein
Journal:  Nat Chem Biol       Date:  2015-11-02       Impact factor: 15.040

Review 3.  Heparan sulfate: a complex polymer charged with biological activity.

Authors:  John M Whitelock; Renato V Iozzo
Journal:  Chem Rev       Date:  2005-07       Impact factor: 60.622

4.  Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events.

Authors:  Marco Guerrini; Daniela Beccati; Zachary Shriver; Annamaria Naggi; Karthik Viswanathan; Antonella Bisio; Ishan Capila; Jonathan C Lansing; Sara Guglieri; Blair Fraser; Ali Al-Hakim; Nur Sibel Gunay; Zhenqing Zhang; Luke Robinson; Lucinda Buhse; Moheb Nasr; Janet Woodcock; Robert Langer; Ganesh Venkataraman; Robert J Linhardt; Benito Casu; Giangiacomo Torri; Ram Sasisekharan
Journal:  Nat Biotechnol       Date:  2008-04-23       Impact factor: 54.908

Review 5.  Production and chemical processing of low molecular weight heparins.

Authors:  R J Linhardt; N S Gunay
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

6.  Highly purified antithrombin 3 with heparin cofactor activity prepared by disc electrophoresis.

Authors:  U Abildgaard
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

7.  The clinical onset of heparin is rapid.

Authors:  E K Heres; K Speight; D Benckart; J Marquez; G P Gravlee
Journal:  Anesth Analg       Date:  2001-06       Impact factor: 5.108

8.  Heparan sulfate facilitates Rift Valley fever virus entry into the cell.

Authors:  S M de Boer; J Kortekaas; C A M de Haan; P J M Rottier; R J M Moormann; B J Bosch
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

9.  Chemoenzymatic synthesis with distinct Pasteurella heparosan synthases: monodisperse polymers and unnatural structures.

Authors:  Alison E Sismey-Ragatz; Dixy E Green; Nigel J Otto; Martin Rejzek; Robert A Field; Paul L DeAngelis
Journal:  J Biol Chem       Date:  2007-07-11       Impact factor: 5.157

Review 10.  From Farm to Pharma: An Overview of Industrial Heparin Manufacturing Methods.

Authors:  Jan-Ytzen van der Meer; Edwin Kellenbach; Leendert J van den Bos
Journal:  Molecules       Date:  2017-06-21       Impact factor: 4.411

View more
  5 in total

1.  Expression and characterization of heparinase II with MBP tag from a novel strain, Raoultella NX-TZ-3-15.

Authors:  Yinyin Li; Yue Lin; Yingzi Jiang; Hafiza Mahreen Mehwish; Muhammad Shahid Riaz Rajoka; Liqing Zhao
Journal:  Arch Microbiol       Date:  2022-08-11       Impact factor: 2.667

2.  Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates.

Authors:  Richard Karlsson; Pradeep Chopra; Apoorva Joshi; Zhang Yang; Sergey Y Vakhrushev; Thomas Mandel Clausen; Chelsea D Painter; Gergo P Szekeres; Yen-Hsi Chen; Daniel R Sandoval; Lars Hansen; Jeffrey D Esko; Kevin Pagel; Douglas P Dyer; Jeremy E Turnbull; Henrik Clausen; Geert-Jan Boons; Rebecca L Miller
Journal:  Sci Adv       Date:  2021-12-22       Impact factor: 14.136

3.  Effects of Heat Stress and Exogenous Salicylic Acid on Secondary Metabolites Biosynthesis in Pleurotus ostreatus (Jacq.) P. Kumm.

Authors:  Yanru Hu; Qianqian Chai; Yue Wang; Yujie Chen; Haozhe Dong; Jinwen Shen; Yuancheng Qi; Haiyou Yu; Fengqin Wang; Qing Wen
Journal:  Life (Basel)       Date:  2022-06-17

Review 4.  Carbohydrate-based drugs launched during 2000-2021.

Authors:  Xin Cao; Xiaojing Du; Heng Jiao; Quanlin An; Ruoxue Chen; Pengfei Fang; Jing Wang; Biao Yu
Journal:  Acta Pharm Sin B       Date:  2022-05-23       Impact factor: 14.903

Review 5.  Comprehensive Landscape of Heparin Therapy for COVID-19.

Authors:  Chen Shi; Wu Tingting; Jin-Ping Li; Mitchell A Sullivan; Cong Wang; Hanxiang Wang; Bin Deng; Yu Zhang
Journal:  Carbohydr Polym       Date:  2020-10-22       Impact factor: 10.723

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.